Free Access
Med Sci (Paris)
Volume 26, Number 3, Mars 2010
Page(s) 225 - 226
Section Nouvelles
Published online 15 March 2010
  1. McHutchinson JG, Lawitz EG, Schiffman ML, et al. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med 2009; 361 : 580–93. [Google Scholar]
  2. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461 : 391–401. [Google Scholar]
  3. Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28b with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C. Nat Genet 2009; 41 : 1105–9. [Google Scholar]
  4. Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon-a and ribavirin therapy. Nat Genet 2009; 41 : 1100–4. [Google Scholar]
  5. Conjeevaram HS, Fried MW, Jeffers LJ, et al. Peginterferon and ribavirin treatment in African American and Caucasian patients with hepatitis C genotype 1. Gastroenterology 2006; 131 : 470–7. [Google Scholar]
  6. Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambda mediate antiviral protection through a distinct class of cytokine receptor complex. Nat Immunol 2003; 4 : 8–9. [Google Scholar]
  7. Marcello T, Grakoul A, Barba-Spaeth G, et al. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation knetics. Gastroenterology 2006; 131 : 1887–98. [Google Scholar]
  8. O’Brien TR. Interferon-α, interferon-λ and hepatitis C. Nat Genet 2009; 41 : 1048–50. [Google Scholar]
  9. M. Shiffman, E. Lawitz, A. Zaman, et al. PEG-IFN-l: antiviral activity and safety profile in a 4-week phase 1b study in relapsed genotype 1 hepatitis c infection. J Hepatol 2009; 50 : S237. [Google Scholar]
  10. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461 : 798–802. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.